Broeders Mariëlle E A C, Molema Johan, Hop Wim C J, Folgering Hans T M
Department of Pulmonary Diseases Dekkerswald, University of Nijmegen, Groesbeek, The Netherlands.
J Aerosol Med. 2003 Summer;16(2):131-41. doi: 10.1089/089426803321919898.
Turbuhaler and Salbutamol-Diskus produce therapeutic doses at peak inspiratory flow (PIF) of >30 L/min. However, the optimum flow for Fluticasone-Diskus and Turbuhaler, in terms of total emitted dose and fine particle mass, is >60 L/min. The Turbuhaler achieved a higher output at this flow, as compared to Diskus. For pMDI 25 < PIF < 90 L/min, an actuation time of 0.0-0.2 sec is optimal. The aim of this study was to examine the incidence of optimum inhalation profiles, the effect of instruction, reproducibility, and the relationship between inhalation profiles and patient characteristics in stable asthmatics and mild/moderate/severe COPD patients. For each device, triplicate inhalation profiles were recorded during 6 sessions in a 10-week period. All patients achieved PIF > 30 L/min using Diskus. After instruction, all Diskus inhalations were performed with >60 L/min, except 7% of the inhalations of the severe COPD patients. At least 95% of the Turbuhaler inhalations was also performed with the minimum flow; however, 19% of the inhalations of the severe COPD patients were not optimally performed. The hand-lung coordination was inadequate in 40% of pMDI inhalation profiles, and 80% was performed with a too high flow. The reproducibility of PIF of both dry powder inhalers (DPIs) was very high (coefficient of variation = 4-10%). The reproducibility of the pMDI variables was lower (coefficient of variation = 9-18%). The major lung function variables predictive for PIF(diskus) and PIF(turbuhaler) were maximal inspiratory mouth pressure (MIP), PIF, and inspiratory capacity. No significant predictive lung function variables for PIF(pMDI) were found. Most patients performed reproducible optimum inhalation profiles through Diskus and Turbuhaler. However, in the severe COPD group, 7-19% of the patients were not able to generate the optimum flows through the DPIs. For these patients, a flow-independent aerosol delivery system might be more suitable. The majority of patients were using the pMDI incorrectly. Instruction had no effect. So, we concluded that the pMDI should not be used in these patient groups because of the coordination problems.
都保和沙丁胺醇碟式吸入器在吸气峰值流速(PIF)>30升/分钟时产生治疗剂量。然而,就总喷出剂量和细颗粒质量而言,氟替卡松碟式吸入器和都保的最佳流速>60升/分钟。与碟式吸入器相比,都保在该流速下的输出更高。对于压力定量吸入器(pMDI),当25<PIF<90升/分钟时,0.0 - 0.2秒的启动时间是最佳的。本研究的目的是检查稳定期哮喘患者以及轻度/中度/重度慢性阻塞性肺疾病(COPD)患者中最佳吸入曲线的发生率、指导的效果、可重复性以及吸入曲线与患者特征之间的关系。对于每种装置,在10周内的6次吸入过程中记录三次重复的吸入曲线。所有患者使用碟式吸入器时PIF>30升/分钟。指导后,除了7%的重度COPD患者的吸入外,所有碟式吸入器的吸入均以>60升/分钟的流速进行。至少95%的都保吸入也以最低流速进行;然而,19%的重度COPD患者的吸入操作未达到最佳。在40%的pMDI吸入曲线中,手 - 肺协调性不足,且80%的操作流速过高。两种干粉吸入器(DPI)的PIF可重复性非常高(变异系数 = 4 - 10%)。pMDI变量的可重复性较低(变异系数 = 9 - 18%)。预测PIF(碟式吸入器)和PIF(都保)的主要肺功能变量是最大吸气压(MIP)、PIF和吸气容量。未发现预测PIF(pMDI)的显著肺功能变量。大多数患者通过碟式吸入器和都保进行了可重复的最佳吸入曲线操作。然而,在重度COPD组中,7 - 19%的患者无法通过干粉吸入器产生最佳流速。对于这些患者,一种与流速无关的气雾剂输送系统可能更合适。大多数患者使用pMDI不正确。指导没有效果。因此,我们得出结论,由于协调问题,pMDI不应用于这些患者群体。